Page 13 - Collaborative Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

El pasado 10 de julio se realizó con éxito el festival benéfico Musitón, organizado por la Red Colaborativa de Artistas. El evento tenía el objetivo de recaudar fondos para los músicos de Cochabamba afectados por el virus. Participaron más de 20 artistas, quienes contribuyeron con su talento en el concierto virtual que fue transmitido por Univalle TV, Comteco TV y redes sociales. La organización anunció que este lunes, 19 de julio, se cerrará la campaña a través del programa Mattinata de Univalle TV, en el que además se sortearán productos de los auspiciadores y colaboradores....

 E-Mail IMAGE: A research participant in the MS pilot study does exercise training in the Ekso NR at Kessler Foundation. view more  Credit: Kessler Foundation/Jody Banks East Hanover, NJ. May 28, 2021. A team of multiple sclerosis (MS) experts at Kessler Foundation led the first pilot randomized controlled trial of robotic-exoskeleton assisted exercise rehabilitation (REAER) effects on mobility, cognition, and brain connectivity in people with substantial MS-related disability. Their results showed that REAER is likely an effective intervention, and is a promising therapy for improv...

APEIRON Biologics' APN01 selected for large-scale US trial in COVID-19 DGAP-News: APEIRON Biologics AG / Key word(s): Study 19.05.2021 / 09:00 APEIRON Biologics' APN01 selected for large-scale US trial  in COVID-19 APEIRON's APN01 to participate in US Phase 2 COVID-19 trial ACTIV-4d RAAS Further clinical study in preparation with inhalative drug delivery of APN01 to directly target respiratory tract and lung tissue Additional pre-clinical data show highly promising results with APN01 in various mutation variants Financing round planned to secure funding of further upcoming development ste...

APEIRON Biologics AG: APEIRON Biologics' APN01 Selected for Large-Scale US Trial in COVID-19 APEIRON's APN01 to participate in US Phase 2 COVID-19 trial ACTIV-4d RAAS Further clinical study in preparation with inhalative drug delivery of APN01 to directly target respiratory tract and lung tissue Additional pre-clinical data show highly promising results with APN01 in various mutation variants Financing round planned to secure funding of further upcoming development steps VIENNA, AUSTRIA / ACCESSWIRE / May 19, 2021 / APEIRON Biologics AG announced today the next development steps for APN01 (al...

 E-Mail IMAGE: DEVCOM ARL researcher Dr. Niranjan Suri, will receive the NATO Science and Technology Organization's Information Systems Technology Panel Individual Excellence Award. view more  Credit: U.S. Army ADELPHI, Md. -- A U.S. Army researcher received high honors from NATO for driving innovation for military communication systems. Dr. Niranjan Suri, a researcher with the U.S. Army Combat Capabilities Development Command, now referred to as DEVCOM, Army Research Laboratory, received the NATO Science and Technology Organization's Information Systems Technology Panel Individual ...